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High performance liquid chromatography/mass spectrometry (HPLC/MS) has become a
widely used technique for routine analysis of pharmaceutical compounds. The constant search
for new drugs requires the development of time-efficient methods that can be employed in
high-throughput screening of combinatorial libraries of a variety of compounds, including
amines and peptides. Conventional HPLC/MS is a powerful technique that can easily be
automated and is suitable for comprehensive screening purposes. However, the unequivocal
determination of the presence and location of important carbamoyl protecting groups of
amines is often elusive because of their inherent instability under MS conditions. In this study,
the use of on-column H/D exchange HPLC/ESI/MS for structure elucidation of t-Boc
protecting groups which can often not be detected by MS because of facile McLafferty
rearrangement has been examined. We demonstrate that employing a deuterated mobile phase
in HPLC/MS analysis provides a convenient tool for the determination of the absence or
presence of t-Boc protecting groups in amines and peptides. (J Am Soc Mass Spectrom 2005,
16, 553–564) © 2005 American Society for Mass SpectrometryAfast and unequivocal identification of the pres-ence and location of t-Boc protecting groupsplays an essential role in routine analysis and
high-throughput screening of combinatorial libraries of
complex amines or peptides. The widespread use of the
t-Boc protecting group in organic synthesis and in
particular in peptide chemistry requires a reliable
method for the fast determination of its absence or
presence in amines and amino acids. Although
HPLC/MS is a very powerful technique for the deter-
mination of the structure of organic compounds, infor-
mation about the labile t-Boc functionality is often
elusive because of the fast McLafferty rearrangement of
the tert-butyl carbamoyl group. For example, t-Boc
protected amino alcohol 1 readily undergoes McLaf-
ferty rearrangement under standard MS conditions to
form fragment 2 exhibiting m/z 152, Scheme 1 [1]. This
fragmentation pathway may proceed via a labile inter-
mediate carbamoyl acid intermediate 3, which easily
eliminates carbon dioxide and is therefore often not
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doi:10.1016/j.jasms.2005.01.008observed. Because the unprotected amino alcohol 4
affords fragment 2 after ionization in the MS detector,
mass spectrometry does not provide a means to differen-
tiate between 1 and 4, i.e., the determination of the
presence of the t-Boc group requires isolation and further
spectroscopic analysis or the use of reference samples for
a time-consuming comparison of HPLC retention times
which is unsuitable for high-throughput screening.
Structure elucidation by mass spectrometry has be-
come increasingly successful through the introduction
of chemical ionization with ND3, D2O, and CD3OD for
exchange of hydrogen for deuterium of organic com-
pounds in the gas phase [2]. This technique can be
applied to H/D exchange MS analysis of various classes
of compounds including alcohols, carboxylic acids,
amines, amides, and thiols [3]. It has also been shown
that hydrogens bonded to carbon atoms in aromatic
compounds can be replaced by deuterium in the gas
phase [4]. The coupling of HPLC and mass spectrome-
try combines a powerful separation technique with the
sensitive and informative MS detection mode, which
opens a new venue for H/D exchange MS analysis of
complex mixtures containing polar compounds. To
date, various MS techniques including chemical ioniza-
tion detection mass spectrometry (CI/MS) [5], fast atom
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secondary ion mass spectrometry (LSI/MS) [7], electro-
spray mass spectrometry (ESI/MS) [8], and thermos-
pray mass spectrometry (TSP/MS) [9] utilizing a deu-
terated mobile phase or matrix have been reported.
Deuterated mobile phase HPLC has also successfully
been combined with NMR [10] and IR spectroscopy
[11].
We report herein the use of deuterated mobile phase
HPLC/MS for the fast elucidation of the absence or
presence of t-Boc protection groups in amines and
peptides. Employing on-line H/D exchange HPLC/
ESI/MS in the analysis of aminopyridines and 16
dipeptides, both t-Boc protected and unprotected, we
found that the presence and position of this labile
protecting group as well as the amino sequence can
readily be identified.
Experimental
All dipeptides studied herein were synthesized from
commercially available t-Boc protected amino acids and
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Scheme 1. McLafferty rearrangement oHPLC/MS.amino acid methyl esters using PyBop (benzotriazole-
1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophos-
phate) as the coupling agent [12]. Hydrolysis under
mild acidic conditions allowed selective cleavage of the
t-Boc group to afford the corresponding unprotected
dipeptides. All samples were analyzed using an Agilent
(Palo Alto, CA) or HP/Bruker (Billerica, MA) ion trap
mass spectrometer equipped with Agilent 1100 HPLC
systems. The replacement of a nondeuterated with a
deuterated mobile phase can cause minor peak shifts. It
should be noted that differences in elution times ex-
ceeding 0.1 min. observed with some of the samples
studied are not a consequence of employing a deuter-
ated mobile phase. In these cases, the sample was
analyzed on two instruments with different voids, i.e.,
the change in retention time is not inherent to the HPLC
method used but due to different instrumental setups.
The samples were evaluated by flow injection analysis
(FIA) and HPLC/ESI/MS. The MS data were collected
using in-source CID (collisionally-induced dissocia-
tion), which may be enhanced by varying the potential
between the skimmer and the capillary exit to increase
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was 50–850 Da. The capillary exit voltage was set at
4000 V and the fragmentor voltage was 80 V. The
drying gas temperature was 350 °C and the flow was 12
L/min. Nebulizer pressure was set at 60 psi. HPLC
separation of dipeptides 5–20 was performed using a
Waters YMC ODS AM column (4.6  250 mm, 5 mm)
and a standard linear gradient over 40 min starting
from 95%/5%/0.1% to 5%/95%/0.1% water/acetoni-
trile/TFA at a flow rate of 1 mL/min at ambient
temperature. The deuterium exchange experiments
were performed using identical conditions replacing
water and TFA with deuterium oxide and d-TFA,
respectively, as has previously been described [7].
Results and Discussion
We assumed that on-line H/D exchange HPLC/
ESI/MS would allow differentiation between analytes 1
and 4 and derivatives thereof. Employing a deuterated
mobile phase in HPLC should afford complete deute-
rium exchange for molecules containing unprotected
amino functions such as 4, whereas protected amines
such as 1 can not undergo proton/deuterium exchange,
Scheme 2. During fragmentation amines carrying a
t-Boc group will undergo a McLafferty rearrangement
transferring a hydrogen from a methyl group of the
t-Boc moiety to the amino function or to the carbonyl
oxygen forming an intermediate carbamoyl acid. The
protection of 1 thus prevents incorporation of deute-
rium into the amino group during chromatography. As
a result, using a deuterated mobile phase in LC/MS
analysis affords distinguishable MS fragments d-2 and
d2-2 corresponding to 1 and 4, respectively.
Our on-column H/D exchange HPLC/ESI/MS strat-
egy was first utilized for the analysis of a three compo-
nent mixture containing unknown aminopyridines, Fig-
ure 1. Comparison of the mass spectra obtained by MS
following nondeuterated and deuterated mobile phase
HPLC gave invaluable information for structure eluci-
0 5 10 15 20 25 Time [min]
0.0
0.5
1.0
1.5
7x10
Intens.
A
B
C
Figure 1. HPLC separation of a mixture of 3 unknown amino-
pyridines.dation of each peak. (Figure 2)Peak A does not carry any protecting groups on its
amino or alcohol functions and affords a (M  H) ion
signal at m/z 153 and an ion fragment at m/z 135, which
can be attributed to elimination of water. The deute-
rium exchange data show the corresponding signals at
m/z 136 and 156 and thus prove the presence of two
exchangeable protons, which is consistent with the
proposed structure. Since H/D back-exchange is com-
mon with amines, a signal at m/z 136 (M  D  D2O)

and m/z 137 (M  D  HOD) is observed. The mass
spectrum obtained for Peak B by conventional
HPLC/MS is misleading because the data suggest a
molecular weight of 166 Da according to the (M  H)
ion signal at m/z 167, Figure 3. However, the deuterated
mobile phase experiment reveals a (M  D) ion signal
at m/z 169 indicating the presence of only one exchange-
able hydrogen which can be attributed to the carboxylic
acid function. [On-column H/D exchange HPLC/
ESI/MS analysis using a sample treated with dia-
zomethane for selective methylation of the free carbox-
ylic acid group provided further evidence for this
asumption.] By contrast, the secondary amino function
does not undergo H/D exchange because it carries a
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Figure 2. ESI mass spectrum of Peak A. HPLC was performed on
a YMC ODS AM column using CH3CN/H2O/CH3CO2H (top)
and CH3CN/D2O/CH3CO2D (bottom) as the mobile phase.t-Boc group. The hydrogen attached to the amino group
556 WOLF ET AL. J Am Soc Mass Spectrom 2005, 16, 553–564in the major fragment is a consequence of intramolecu-
lar hydrogen transfer through McLafferty rearrange-
ment. Due to H/D back-exchange, a signal at m/z 150
(MDHOD) is observed. The deuterium exchange
MS data clearly reveal the presence and position of the
t-Boc group even though the molecular ion or the
corresponding carbamoyl acid fragment, which would
be indicative of a McLafferty rearrangement, can not be
observed.
Routine analysis of the mass spectrum obtained for
Peak C obtained with a nondeuterated mobile phase
indicates the presence of a carboxylic acid with a
molecular weight of 166 Da, which would be in accor-
dance with a (M  H) molecular ion signal at m/z 167,
Figure 4 (top panel). [The shown carbamoyl acid exhib-
iting a molecular weight of 166 Da would not be stable
during HPLC analysis. Accordingly, one would predict
the presence of a carboxylic acid isomer, e.g., 2-(6-
methylamino-2-pyridyl)acetic acid.] However, the cor-
responding ion signal following H/D exchange is ob-
served at m/z 168 and suggests that exchangeable
hydrogens are not present in this molecule. The de-
tected fragment must therefore be a consequence of a
McLafferty rearrangement of a t-Boc protected tertiary
amine, which does not undergo H/D exchange. Assum-
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Figure 3. ESI mass spectrum of Peak B. HPLC was performed on
a YMC ODS AM column using CH3CN/H2O/CH3CO2H (top)
and CH3CN/D2O/CH3CO2D (bottom) as the mobile phase.ing an intramolecular hydrogen transfer from a t-Bocgroup to a carbonyl oxygen, the signals exhibiting m/z
167 and 168, respectively, can be assigned to a car-
bamoyl acid fragment generated under MS conditions
after chromatographic separation.
We decided to prepare sixteen representative dipep-
tides to further study the use of our on-column H/D
exchange HPLC/ESI/MS method for structure elucida-
tion of N-terminal t-Boc-protected dipeptides and their
unprotected analogs, Figure 5.
Employing a deuterated mobile phase in the chro-
matographic separation of dipeptides 5–20 should re-
sult in complete proton/deuterium exchange for all
protons attached to a heteroatom. At the N-terminus,
the unprotected dipeptides 5, 7, 9, 13, 15, 17, and 19 can
exchange two protons (but only one proton in dipeptide
11), whereas the t-Boc protected derivatives 6, 8, 10, 14,
16, 18, and 20 can only exchange one proton for
deuterium (none in 12). In addition, the amide protons
and the proton of the Z-carbamate group of the orni-
thine derivatives 15 and 16 will also be exchanged. In
accordance with the results obtained with aminopyri-
dines, we expected that comparison of mass spectral
data obtained in conjunction with nondeuterated and
deuterated HPLC would provide clear evidence of the
presence and position of t-Boc groups.
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Figure 4. ESI mass spectrum of Peak C. HPLC was performed on
a YMC ODS AM column using CH3CN/H2O/CH3CO2H (top)
and CH3CN/D2O/CH3CO2D (bottom) as the mobile phase.Comparison of the HPLC/CID/MS spectral data
re of
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mobile phase reveals the presence of three exchange-
able protons, Figures 6 and 7. The molecular ion is
easily detected by conventional MS analysis as its (M 
H) or (M  Na) signal respectively at m/z 203 and
Figure 5. StructuFigure 6. HPLC/CID/MS data of dipeptide225. Deuterated mobile phase HPLC/MS affords the
corresponding strong signals at m/z 207 (d3-M  D)

and 228 (d3-M  Na)
. Because of the low stability of
t-Boc groups discussed above, on-line H/D exchange
MS data are necessary to clearly prove the absence of a
dipeptides 5–20.5 using a nondeuterated mobile phase.
eptid
558 WOLF ET AL. J Am Soc Mass Spectrom 2005, 16, 553–564t-Boc group in 5 and also allow one to exclude possibly
coeluting t-Boc-protected impurities.
The MS data of Dipeptide 6 show that one t-Boc
group is incorporated into the N-terminus, Figures 8
and 9. This dipeptide affords two exchangeable pro-
tons, one on the t-Boc protected amino function and one
attached to the peptide bond. As the molecule frag-
ments, the t-Boc protected amine acquires an additional
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ventional HPLC/MS data would also indicate the pres-
ence of one t-Boc group because of the (M  Na) ion
signal at m/z 325, the deuterated mobile phase
HPLC/MS approach allows one to exclude the presence
of additional carbamate functions. It should be noted
that the MS data of 6 obtained using a nondeuterated
mobile phase in the preceding HPLC separation contain
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dipeptide 5, i.e., fragments at m/z 203 and 225. It is very
well known that the t-Boc protection group is readily
cleaved under mild acidic conditions. This often com-
plicates the analysis of such carbamates because unde-
sirable cleavage can occur during isolation and purifi-
cation steps of t-Boc protected compounds or during
chromatographic analysis. The coexistence of 5 and 6
160.2
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Figure 9. HPLC/CID/MS data of dipFigure 10. HPLC/CID/MS data of dipeptidecould also be a consequence of incomplete derivatiza-
tion of the unprotected dipeptide. However, Figure 9
shows the prevalence of fragments at m/z 206 and 227
observed in the mass spectra after H/D exchange and
the low intensity of fragments exhibiting a m/z 207 and
228, which may be attributed to H/D back exchange
and 13C content of the sample, provides evidence that
dipeptide 6 is not contaminated with 5, Figure 9.
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HPLC/MS methodology to Compound 15 carrying a
benzyloxycarbonyl carbamate reveals the presence of
four hydrogens which readily exchange in the deuter-
ated mobile phase, Figures 10 and 11. The ions at m/z
394, 399, 416, and 420 corresponding, respectively, to (M
 H), (d4-M  D)
, (M  Na), and (d4-M  Na)

refer to the molecular ion of 15. Again, comparison of
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HPLC/MS analysis of the N-t-Boc protected dipep-
tide 16 shows three exchangeable hydrogens, one on the
t-Boc protected amino function, one on the Z-carbamate
and one on the peptide bond, Figures 12 and 13.
Deuterated mobile phase HPLC followed by MS frag-
mentation of 16 results in incorporation of only one
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moiety. As expected, the amide bond and the Z-pro-
tected -amino group of the ornithine moiety show
exchange of one proton for deuterium. Comparison of
the fragment with m/z 394 and its C-13 isotope pattern
to the signal of the corresponding fragment obtained by
HPLC/MS using a deuterated mobile phase exhibiting
m/z 398 proves that 16 carries one t-Boc group and also
226.2
269.1
0.0
0.5
1.0
1.5
2.0
2.5
3.0
6x10
Intens.
150 175 200 225 250 2
C20H24N2O4 MW 356
H2N
H
N
O
O
O
O
H2N
O
+ H
+
(m/z 286 - N
m/z 26
207.2 223.2
289.3
335
0.0
0.2
0.4
0.6
0.8
1.0
1.2
7x10
Intens.
150 200 250 300
N
D
N
O
O
D
N
O
O
D
H
Deuterium Exchange
N
O
H
D
(m/z 354 - NH
m/z 335
N
D
N
O
H
D
O N
D
O
D
N
O
O
D
N O
O
O
C25H36D3N3O7 MW 496
+ D
+
HN
D
N O
O
Figure 13. HPLC/CID/MS data of dipFigure 14. HPLC/CID/MS data of dipeptideallows exclusion of the presence of impurities of 15 in
this sample. Deuterated mobile phase HPLC/MS data
thus afford clear information about the purity and the
presence and location of different carbamoyl protection
groups of complex molecules.
Dipeptide 19 carrying a benzyl protecting group and
20,which also affords a t-Boc group, were also analyzed
by on-column H/D exchange HPLC/MS. The spectral
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562 WOLF ET AL. J Am Soc Mass Spectrom 2005, 16, 553–564MS data observed for 19 reveal three exchangeable
protons and confirm the presence of the benzyl group,
Figures 14 and 15. The location of the benzyl group
becomes evident from the fragmentation pattern of 19
and d3-19. The CID/MS of 19 shows a fragment refering
to a benzylated methyl tyrosine ester (nondeuterated
ionm/z 286, deuterated ionm/z 289) that eliminates NH3
or ND3 to give a fragment at m/z 269. The presence of
Figure 15. HPLC/CID/MS data of dipFigure 16. HPLC/CID/MS data of dipeptidethis fragment ion and the H/D exchange MS data
pattern reveal that the benzyl group must be attached to
the phenol moiety of tyrosine but not to its amino
function.
The analysis of Dipeptide 20 provides complete
structural information about the presence and location
of the protecting groups, Figures 16 and 17. Two
exchangeable protons were detected and assigned to
e 19 using a deuterated mobile phase.20 using a nondeuterated mobile phase.
eptid
563J Am Soc Mass Spectrom 2005, 16, 553–564 ELUCIDATION OF t-Boc GROUPS USING H/D EXCHANGEprotons attached to the peptide bond and one carbam-
ate function. Again, MS data of nondeuterated 20 could
be misinterpretated because of the intensive fragment at
m/z 357 suggesting the presence of 19 as an impurity.
This can be ruled out by comparison to the correspond-
ing fragment obtained with deuterated 20. The frag-
ment ion exhibiting m/z 360 carries a hydrogen attached
to a nitrogen and therefore must be assigned to a
McLafferty rearrangement fragment of 20. The ion
signals at m/z 286 and 357 (nondeuterated sample) and
m/z 288 and 360 (deuterated sample) in conjunction
with the fragment exhibiting m/z 269 reveal that the
t-Boc group is attached to the alanine moiety at the
N-terminus. H/D Exchange MS data thus also provides
a tool for differentiating between N-t-Boc-(S)-Ala-O-Bn-
(S)-Tyr-OMe, 20, and N-t-Boc-O-Bn-(S)-Tyr-(S)-Ala-
OMe, i.e., applying this method to structure elucidation
of 5–20 affords invaluable information about the amino
acid sequence in addition to the presence and location
of t-Boc protecting groups attached to these dipeptides.
On-column H/D exchange HPLC combined with
mass spectrometry was also utilized for the analysis of
Dipeptides 7–14, 17, and 18. In all cases, we found that
this methodology greatly facilitates structure elucida-
tion, i.e., determination of position and number of t-Boc
protecting groups and information about the primary
peptide structure. It also allows one to examine the
presence or absence of coeluting impurities that exhibit
the same MS spectrum using conventional HPLC/MS.
Conclusions
The usefulness of deuterated mobile phase HPLC/MS
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Figure 17. HPLC/CID/MS data of dipfor a fast determination of the absence or presence oft-Boc protection group in various amines and peptides
has been demonstrated. This technique also allows for
the determination of the presence of unprotected impu-
rities that may result from undesirable carbamate cleav-
age under mild acidic conditions or incomplete deriva-
tization. Employing this strategy in mass spectral
structural elucidation is expected to be invaluable for
routine MS analysis of complex molecules and for fast
screening of combinatorial libraries that require a rapid
and automated analysis of the presence and location of
t-Boc protecting groups.
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